Request Customization - North America Cannabis Market Expects around 27.7% CAGR During 2022-27

North America Cannabis Market Research Report: Forecast (2022-2027)

By Application (Medical Use {Chronic Pain, Mental Disorder, Cancer, Others [Nausea, Muscle Spasms, Migraine, Glaucoma], Self-Consumption / Private Use), By Product Type (Flower, Oil), By Distribution... ... l), By Distribution Channel (Regulated Dispensary, Recreational Stores, Stand-Alone Retailers, Online Portals), By End-User (Patients, Research Institute, Research Companies), By Country (US, Canada, Mexico), By Company (22nd Century Group Inc., Medical Marijuana Inc., Hemp Inc., Axim Biotechnologies Inc., Arena Pharmaceuticals Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc., Abcann Medicinals Inc.) Read more

Healthcare
Dec 2021
Pages 178
Report Format: PDF, Excel, PPT

Market Definition

Cannabis is a general term used for indicating the several psychoactive preparations of the plant Cannabis sativa. The key psychoactive constituent present in cannabis is Delta-9 tetrahydrocannabinol (THC). It is a drug derived from the dried flowers & leaves of the hemp plant that grow in the tropical & temperate areas of the world. Cannabis is also known as hash, weed, pot, marijuana, dope, cone, and smoke.

Market Insights

The North America Cannabis Market is anticipated to grow at a CAGR of around 27.7% during the forecast period, i.e., 2022-27, says MarkNtel Advisors. The growing legal landscape in North America is offering a way to the full legalization & decriminalization of cannabis, which is why it is gaining immense prominence for both recreational & medical purposes.

Marijuana is illegal under federal law, but an increasing number of states legalizing this drug for medical or recreational uses in recent years is likely to boost the North America Cannabis Market. Till November 2020, 36 states and three territories have adopted comprehensive medical cannabis programs, and 15 states have approved sales of adult-use cannabis in the US. Further, the legalization of adult-use cannabis is expected to continue increasing in the coming years.

Moreover, the existing medical cannabis programs are highly regulated, controlling patient & supplier access. However, medical cannabis sales are expected to increase significantly in the coming future.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR (2022-2027)	27.7%
Countries Covered	North America: USA, Canada, Mexico
Key Companies Profiled	22nd Century Group Inc, Medical Marijuana Inc, Hemp Inc, Axim Biotechnologies Inc, Arena Pharmaceuticals Inc., Canopy Growth Corporation, Aphria Inc, Aurora Cannabis Inc, Abcann Medicinals Inc
Unit Denominations	USD Million/Billion

Impact of COVID-19 on the North America Cannabis Market

Last year, the COVID-19 pandemic increased the uncertainty levels of many businesses and created heavy economic, fiscal, & social pressure.
The North America Cannabis Market was no exception as the leading industry players like Aurora & Canopy Growth faced layoffs and closed facilities, which, in turn, impacted the market growth to a certain extent.
However, with the increasing demand for medical cannabis to treat symptoms like vomiting, headache, & pain caused due to COVID-19, sales of adult-use cannabis products rapidly increased.
Moreover, many companies shifted their focus on e-commerce platforms & social media to reach their consumers amidst the crisis, with which the market observed a hike.
Additionally, due to the increasing sales of medical cannabis across the US & Canada, the market is expected to witness significant growth in the coming years.

Introduction
1. Market Segmentation
2. Product Definition
3. Research Process
4. Assumptions
Executive Summary
Impact of COVID-19 on the North America Cannabis Market
North America Cannabis Market Policies, Regulations, Product Standards
North America Cannabis Market Trends & Insights
North America Cannabis Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
North America Cannabis Market Hotspot & Opportunities
North America Cannabis Market Key Strategic Imperatives for Success & Growth
North America Cannabis Market Analysis, 2017-2027F
1. Market Size & Analysis
  1. By Revenue
2. Market Share & Analysis
  1. By Application
    1. Medical Use
      1. Chronic Pain
      2. Mental Disorder
      3. Cancer
      4. Others (Nausea, Muscle Spasms, Migraine, Glaucoma)
    2. Self-Consumption / Private Use
  2. By Product Type
    1. Flower
    2. Oil
  3. By Distribution Channel
    1. Regulated Dispensary
    2. Recreational Stores
    3. Stand-Alone Retailers
    4. Online Portals
  4. By End-User
    1. Patients
    2. Research Institute
    3. Research Companies
  5. By Country
    1. US
    2. Canada
    3. Mexico
  6. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitive Matrix
The US Cannabis Market Analysis, 2017-2027F
1. Market Size and Analysis
  1. By Revenue
2. Market Share and Analysis
  1. By Application
  2. By Product Type
  3. By Distribution Channel
  4. By End-User
Canada Cannabis Market Analysis, 2017-2027F
1. Market Size and Analysis
  1. By Revenue
2. Market Share and Analysis
  1. By Application
  2. By Product Type
  3. By Distribution Channel
  4. By End-User
Mexico Cannabis Market Analysis, 2017-2027F
1. Market Size and Analysis
  1. By Revenue
2. Market Share and Analysis
  1. By Application
  2. By Product Type
  3. By Distribution Channel
  4. By End-User
Competitive Outlook
1. Research & Development
2. Strategic Alliance
3. Strategic Initiatives
4. Financial Performance
Company Profile
1. 22nd Century Group Inc
2. Medical Marijuana Inc
3. Hemp Inc
4. Axim Biotechnologies Inc
5. Arena Pharmaceuticals Inc.
6. Canopy Growth Corporation
7. Aphria Inc
8. Aurora Cannabis Inc
9. Abcann Medicinals Inc
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Name *

Email *

Country *